Anne-perrine P. Foray

Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Assessment of soluble PD-L1 in septic shock in relation to immunosuppressive phenotypes.

Assessment of soluble PD-L1 in septic shock in relation to immunosuppressive phenotypes.

Journal: Annals of intensive care

Published: November 13, 2025

Immunological impact of age and comorbidities: findings from the REALISM and SENIOR-HLA-DR cohorts.

Immunological impact of age and comorbidities: findings from the REALISM and SENIOR-HLA-DR cohorts.

Journal: Aging clinical and experimental research

Published: September 26, 2025

Dazukibart for the treatment of severe TIF1γ-positive juvenile dermatomyositis.

Dazukibart for the treatment of severe TIF1γ-positive juvenile dermatomyositis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 17, 2025

Dazukibart for the treatment of severe TIF1γ-positive juvenile dermatomyositis.

Dazukibart for the treatment of severe TIF1γ-positive juvenile dermatomyositis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 17, 2025

Type I interferon as a pre-lupus marker in anti-nuclear antibody-associated childhood immune thrombocytopenic purpura.

Type I interferon as a pre-lupus marker in anti-nuclear antibody-associated childhood immune thrombocytopenic purpura.

Journal: British journal of haematology

Published: December 31, 2024

Myositis-specific autoantibody subtypes are associated with response to Janus kinase inhibitors in patients with juvenile dermatomyositis.

Myositis-specific autoantibody subtypes are associated with response to Janus kinase inhibitors in patients with juvenile dermatomyositis.

Journal: Rheumatology (Oxford, England)

Published: November 22, 2024

Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders.

Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders.

Journal: The journal of allergy and clinical immunology. Global

Published: April 19, 2024

Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren's disease.

Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren's disease.

Journal: RMD open

Published: January 12, 2024

JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study.

JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study.

Journal: Journal of autoimmunity

Published: January 07, 2024

Occurrence of Lupus-Like Nephritis in a Girl With NLRC4 Gain-of-Function Mutations.

Occurrence of Lupus-Like Nephritis in a Girl With NLRC4 Gain-of-Function Mutations.

Journal: Kidney international reports

Published: November 13, 2023

De novo germline mutation in the dual specificity phosphatase 10 gene accelerates autoimmune diabetes.

De novo germline mutation in the dual specificity phosphatase 10 gene accelerates autoimmune diabetes.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 28, 2021

IL-4 and IL-17 Are Required for House Dust Mite-Driven Airway Hyperresponsiveness in Autoimmune Diabetes-Prone Non-Obese Diabetic Mice.

IL-4 and IL-17 Are Required for House Dust Mite-Driven Airway Hyperresponsiveness in Autoimmune Diabetes-Prone Non-Obese Diabetic Mice.

Journal: Frontiers in immunology

Published: August 14, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026